Identification of neonatal hearing impairment: Distortion product otoacoustic emissions during the perinatal period

Ear and Hearing

Volumn 21, Issue 5, 2000, Pages 400-424

  Gorga, Michael P ^a,b   Norton, Susan J ^c   Sininger, Yvonne S ^d   Cone Wesson, Barbara ^e,i   Folsom, Richard C ^f   Vohr, Betty R ^g   Widen, Judith E ^h   Neely, Stephen T ^a,b  

^a Multicenter Consortium on Identification of Neonatal Hearing Impairment   (United States)

^b BOYS TOWN NATIONAL RESEARCH HOSPITAL   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d HOUSE EAR INSTITUTE   (United States)

^e LAC USC MEDICAL CENTER   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g WOMEN AND INFANTS HOSPITAL   (United States)

^h UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; ENVIRONMENT; HEARING IMPAIRMENT; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; NEWBORN SCREENING; NOISE; PERINATAL PERIOD; RISK FACTOR; SIGNAL NOISE RATIO;

EID: 0033784683     PISSN: 01960202     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003446-200010000-00007     Document Type: Article

References (59)

1. Distortion product otoacoustic emission (2f1 - f2) amplitude as a function of f2/f1 frequency ratio and primary tone level separation in human adults and neonates
2. The development of cochlear frequency resolution in the human auditory system
3. Statistical evaluation of hearing screening by distortion product otoacoustic emissions
4. Preliminary descriptions of transient-evoked and distortion-product otoacoustic emissions from graduates of an intensive care nursery
5. Distortion-product otoacoustic emissions in neonates: Normative data
6. Cochlear traveling wave delays estimated by distortion product otoacoustic emissions in normal hearing adults and term-born neonates
7. Acoustic distortion products (ADP) from the ears of term infants and young adults using low stimulus levels
8. Differences between neonate and adult cochlear mechanical responses
9. Outer hair cell electromotility and otoacoustic emissions
10. External and middle ear status related to evoked otoacoustic emissions in neonates
11. Nonlinear mechanics at the apex of the guinea pig cochlea
12. Two-tone suppression and intermodulation distortion in the cochlea: Effect of outer hair cell lesions
13. The behavior of the acoustic distortion product, 2f1 - f2, from the human ear and its relation to auditory sensitivity
14. Comparing the level of the acoustic distortion product 2f1 - f2 with behavioral threshold audiograms from normal-hearing and hearing impaired ears
15. Towards understanding the limits of distortion product otoacoustic emission measurements
16. Otoacoustic emissions from normal-hearing and hearing impaired ears: Distortion product responses
17. A comparison of transient-evoked and distortion product otoacoustic emissions in normal hearing and hearing-impaired ears
18. From laboratory to clinic: A large scale study of distortion product otoacoustic emissions in ears with normal hearing and ears with hearing loss
19. The use of cumulative distributions to determine critical values and levels of confidence for clinical distortion product otoacoustic emission measurements
20. Distortion product otoacoustic emissions in humans with high frequency sensorineural hearing loss
21. Identification of neonatal hearing impairment: Experimental protocol and database management
22. Joint Committee on Infant Hearing 1994 position statement
23. Identification of neonatal hearing impairment: Ear-canal measurements of acoustic admittance and reflectance in neonates
24. Evidence of mechanical nonlinearity and frequency selective wave amplification in the cochlea
25. Auditory-nerve activity in cats exposed to ototoxic drugs and high intensity sounds
26. Distortion product otoacoustic emission test of sensorineural hearing loss: Performance regarding sensitivity, specificity, and receiver operating characteristics
27. Distortion product emissions and sensorineural hearing loss
28. Predicting pure tone thresholds in normal and hearing-impaired ears with distortion product emissions and age
29. Distortion product emissions and sensorineural hearing loss
30. Distortion product and click-evoked otoacoustic emissions in healthy newborns
31. Distortion product otoacoustic emissions in human newborns and adults. I. Frequency effects
32. Distortion product otoacoustic emissions in human newborns and adults. II. Level effects
33. Distortion product otoacoustic emissions in human newborns and adults
34. Single-neuron labeling and chronic cochlear pathology. III. Stereocilia damage and alterations of threshold tuning curves
35. Distortion product emissions in humans. I. Basic properties in normally-hearing subjects
36. The clinical utility of distortion product otoacoustic emissions
37. Clinical applications of otoacoustic emissions
38. Distortion product otoacoustic emissions in healthy newborns: Normative data
39. Distortion product emissions in humans. III. Influence of sensorineural hearing loss
40. Distortion product emissions and auditory sensitivity in human ears with normal hearing and cochlear hearing loss
41. Identification of neonatal hearing impairment: A multi-center investigation
42. Identification of neonatal hearing impairment: Transient otoacoustic emissions during the perinatal period
43. Identification of neonatal hearing impairment: Evaluation of TEOAE, DPOAE, and ABR test performance
44. Evoked otoacoustic emissions in normal-hearing infants and children: Emerging data and issues
45. Growth of the 2f1-f2 distortion product otoacoustic emission for low-level stimuli in human neonates
46. Basic characteristics of distortion product otoacoustic emissions in infants and children
47. Distortion product otoacoustic emissions in normal and hearing impaired ears
48. Longitudinal distortion product otoacoustic emission (DPE) latency changes in preterm neonates
49. Observations on the vibration of the basilar membrane in squirrel monkeys using the Mossbauer technique
50. Feasibility of acoustic distortion product testing in newborns
51. Evoked otoacoustic emissions arise by two fundamentally different mechanisms: A taxonomy for mammalian OAEs
52. Sound calibration and distortion product otoacoustic emissions at high frequencies
53. Identification of neonatal hearing impairment: Auditory brain-stem response in the perinatal period
54. Distortion product and click-evoked otoacoustic emissions of pre-term and full-term infants
55. Distortion product otoacoustic emissions in normal and impaired adult ears
56. Towards optimizing the clinical utility of distortion product otoacoustic emission measurements
57. Identification of neonatal hearing impairment: Characteristics of infants in the neonatal intensive care unit (NICU) and well baby nursery
58. Dependence of distortion product otoacoustic emissions on primary levels in normal and impaired ears. I. Effects of decreasing L2 below L1
59. Identification of neonatal hearing impairment: Hearing status at 8 to 12 months corrected age using a visual reinforcement audiometry protocol